Imeik Technology Development Co Ltd (SZSE:300896) Share Price

Company Profile

Business description
Imeik Technology Development is a leading Chinese medical aesthetics company, best known for its portfolio of hyaluronic acid-based solutions and gel injectable products. Founded in 2004 and headquartered in Beijing, the company has built its reputation on product innovation and a differentiated strategy, enabling it to rank first in China with a market share by value exceeding 20% in 2024. In 2025, Imeik acquired a controlling stake (approximately 60%) in South Korea’s Regen Biotech through a joint venture with an investment fund. Presently, almost all of Imeik’s revenue is derived domestically in China.
Contact
No. 92A, Jianguo Road
21st Floor, Tower C, Shimao Tower
Chaoyang District
Beijing100022
CHN
T: +86 1085809026
https://www.imeik.net
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
1,458

Recommended

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.

Seth Goldstein, CFA | 31 July 2026

This AI leader qualifies as a GARP stock today.

Brian Colello, CPA | 31 July 2026

Record volumes, lower costs and reduced debt underpin a stronger earnings outlook for ASX miner.

Mark Taylor | 31 July 2026

Index	Last price	Change	% Change
All Ordinaries	9,137.00	70.20	-0.76%
CAC 40	8,509.64	24.00	0.28%
DAX 40	25,629.24	17.21	0.07%
Dow JONES (US)	52,485.03	276.97	0.53%
FTSE 100	10,868.05	29.22	-0.27%
HKSE	25,884.43	25.55	0.10%
NASDAQ	25,373.85	251.68	1.00%
Nikkei 225	64,362.02	2,494.59	4.03%
NZX 50 Index	13,699.28	63.50	-0.46%
S&P 500	7,489.72	52.09	0.70%
S&P/ASX 200	8,976.80	73.10	-0.81%
SSE Composite Index	3,832.26	27.57	0.72%